As the building block to living organisms, cells make up our bodies and perform a wide variety of different functions, all while being the smallest unit of the body. Depending on the tissue type, cells can be more or less specialized.

Single-use manufacturing is the production of a finished product that is designed to be used once. In the biopharmaceutical industry, single-use manufacturing is an important and growing part of the industry.

One of the major technologies introduced to the biotech industry in recent years has been artificial intelligence. Artificial intelligence (AI) is technology that utilizes human patterns and behaviors to mimic their problem solving in order to perform tasks like answering questions or providing relevant information.

In pharmaceutical production, maintaining equipment uptime is essential for operational efficiency and process safety. Particularly in cleanroom environments, unplanned downtime can disrupt workflows, increase overhead costs, and in some cases contribute to delays in drug availability.

During sterile manufacturing, human operators pose the greatest risk for product contamination. To reduce microbiological and particulate contamination risks, aseptic techniques typically rely on either laminar flow equipment used within a cleanroom environment or barrier technology. Laminar flow equipment includes laminar flow hoods and biosafety cabinets (Class I, Class II, and Class III). Barrier technology includes restricted access barrier systems (RABS) and isolators.

Explore the future of pharmaceutical manufacturing with 4 key trends in sterile component transfer. From pre-validated solutions to manufacturing flexibility and increased automation, discover how industry leaders Getinge and West are shaping the landscape.

Discover how our DPTE® rapid transfer port, tested in collaboration with SafeBridge® Regulatory & Life Sciences Group, ensures personnel and environmental safety in pharmaceutical manufacturing facilities. Read the assessment of containment performance, validating the effectiveness of the DPTE® Alpha port against potentially hazardous active pharmaceutical ingredients.

The pharmaceutical industry constantly seeks innovations that enhance the safety, efficiency, and precision of drug production. One such revolutionary technology that has significantly impacted the industry is the DPTE® system, introduced in the 1960s. This article explores the history and evolution of DPTE®, highlighting its pivotal role in pharmaceutical production and the extensive experience that Getinge brings to the table after 60 years in the field.

Personnel and environmental safety are critical for pharmaceutical companies that manufacture drugs with hazardous or potentially hazardous Active Pharmaceutical Ingredients (APIs). APIs are a normal byproduct of pharmaceutical production, research and development that can be released into the loading and service area via the component cleaning/washing process.

The single-use DPTE-BetaBag® is playing an increasingly important role in scale-up and high-speed manufacturing operations by providing an aseptic liquid transfer solution that delivers on safety and sterility. Especially in final filtration and filling operations, maintaining sterility throughout the entire process is critical.

Getinge’s DPTE® Beta containers are used, amongst other applications, for safe and leak-free transfer of highly potent active pharmaceutical ingredients (HPAPI).

In some projects IMA Life works together with Getinge to find advanced solutions to meet the most demanding customer needs.

Educated in the Control and Development of Pharmaceutical Products, Sophie Corbineau worked in pharmaceutical production for eight years, before joining Getinge as a Validation Expert in 2015.

Since beginning her career as an Operator in the 1990s, Cleanroom Supervisor Karine Piquot has studied every aspect of cleanroom production at Getinge.

Following specified load and autoclave cycle parameters will result in the best performance for DPTE-BetaBag® Tyvek®. These easy steps will improve outcomes and reduce the risk of bag failure. Understand how the performance of the DPTE-BetaBag® Tyvek will be optimized by using proper procedures.

The Original DPTE® system from Getinge is the world's leading sterile transfer solution. A fully validated system, DPTE® is available with both single-use DPTE-BetaBag® and reusable Beta Containers to match your needs. Learn more about the advantages of each solution.

The Original DPTE® system from Getinge is the world's leading sterile transfer solution. A fully validated system, DPTE® enables you to efficiently secure requalification in your production. Discover a breakdown of the advantages.

The original DPTE® system from Getinge is the world's leading sterile transfer solution.The most important advantage of using both DPTE® Alpha and DPTE® Beta components is that as one complete system it is validated by Getinge.